With thousands of people dying every day across the planet because of COVID-19, the world sure needs more ways to fight the disease. New hope comes from the Mayo Clinic Health System, as it’s using a new treatment for keeping high-risk COVID patients out of the hospital.
The news comes from weau.com, and the FDA approved emergency use authorization for the new treatment back in Nov. 2020. Known as monoclonal antibody treatments, the new way to fight the SARS-CoV-2 virus consists of proteins made in the lab created to mimic the immune system’s ability to eliminate harmful pathogens.
Meant to kick start the immune system
Mayo Clinic Eau Claire physician assistant Lori Arndt, explains how the new treatment works:
It blocks the virus from attaching to your cells and prevents you from developing severe COVID symptoms.
Bob Wachsmuth is a 70-year-old man who was suffering from chronic pulmonary disease, and he later became infected with COVID-19. Both the man’s age and primary condition were likely making him more vulnerable in the face of COVID-19 than others, but a doctor from Mayo Clinic recommended the patient to receive monoclonal antibodies. Wachsmuth declared:
I had more of a feeling of relief that because I had these underlying things, this was available to me and probably would hasten the recovery and keep me out of the out of the hospital or shorten the stay.
As Bloomberg reveals that over 159 million vaccine doses for COVID-19 were administered worldwide, the world still struggles with large numbers of infections and deaths caused by the ongoing pandemic. Data from worldometers.info reveals that there’s a total of over 108 million COVID infections throughout the world, while the number of those who lost the battle with the coronavirus exceeds 2.3 million.